Role of superoxide anion in regulating pressor and vascular hypertrophic response to angiotensin II.

Our purpose was to address the role of NAPDH oxidase-derived superoxide anion in the vascular response to ANG II. Blood pressure, aortic superoxide anion, 3-nitrotyrosine, and medial cross-sectional area were compared in wild-type mice and in mice that overexpress human superoxide dismutase (hSOD). The pressor response to ANG II was significantly less in hSOD mice. Superoxide anion levels were increased twofold in ANG II-treated wild-type mice but not in hSOD mice. 3-Nitrotyrosine increased in aortic endothelium and adventitia in wild-type but not hSOD mice. In contrast, aortic medial cross-sectional area increased 50% with ANG II in hSOD mice, comparable to wild-type mice. The lower pressor response to ANG II in the mice expressing hSOD is consistent with a pressor role of superoxide anion in wild-type mice, most likely because it reacts with nitric oxide. Despite preventing the increase in superoxide anion and 3-nitrotyrosine, the aortic hypertrophic response to ANG II in vivo was unaffected by hSOD.

[1]  D. Johns,et al.  Role of NADPH Oxidase in the Vascular Hypertrophic and Oxidative Stress Response to Angiotensin II in Mice , 2001, Circulation research.

[2]  O. Carretero,et al.  Upregulation of p67(phox) and gp91(phox) in aortas from angiotensin II-infused mice. , 2000, American journal of physiology. Heart and circulatory physiology.

[3]  C. Epstein,et al.  Overexpression of CuZnSOD in coronary vascular cells attenuates myocardial ischemia/reperfusion injury. , 2000, Free radical biology & medicine.

[4]  C. Epstein,et al.  Role of superoxide in hemorrhagic shock-induced P-selectin expression. , 2000, American journal of physiology. Heart and circulatory physiology.

[5]  N. Vaziri,et al.  Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. , 2000, Hypertension.

[6]  B. Giasson,et al.  Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. , 2000, The Journal of biological chemistry.

[7]  M. Bachschmid,et al.  Hypoxia–Reoxygenation Triggers Coronary Vasospasm in Isolated Bovine Coronary Arteries via Tyrosine Nitration of Prostacyclin Synthase , 1999, The Journal of experimental medicine.

[8]  R. Cohen,et al.  Paracrine role of adventitial superoxide anion in mediating spontaneous tone of the isolated rat aorta in angiotensin II-induced hypertension. , 1999, Hypertension.

[9]  D. Harrison,et al.  Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production. , 1999, Biochemical and biophysical research communications.

[10]  C. Wilcox,et al.  Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin f2alpha. , 1999, Hypertension.

[11]  W R Taylor,et al.  Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. , 1998, Hypertension.

[12]  S. Chanock,et al.  Angiotensin II induces p67phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts. , 1998, Hypertension.

[13]  C. Epstein,et al.  Attenuation of age-dependent oxidative damage to DNA and protein in brainstem of Tg Cu/Zn SOD mice , 1998, Neurobiology of Aging.

[14]  W. Welch,et al.  Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. , 1998, Hypertension.

[15]  K. Murayama,et al.  Inactivation of Human Manganese-superoxide Dismutase by Peroxynitrite Is Caused by Exclusive Nitration of Tyrosine 34 to 3-Nitrotyrosine* , 1998, The Journal of Biological Chemistry.

[16]  P. Brecher,et al.  Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. , 1998, Circulation research.

[17]  J. Zweier,et al.  Validation of Lucigenin (Bis-N-methylacridinium) as a Chemilumigenic Probe for Detecting Superoxide Anion Radical Production by Enzymatic and Cellular Systems* , 1998, The Journal of Biological Chemistry.

[18]  G. Callis,et al.  Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  G. Schmid-Schönbein,et al.  Oxidative stress in the Dahl hypertensive rat. , 1997, Hypertension.

[20]  M. Omata,et al.  Vitamin E ameliorates the renal injury of Dahl salt-sensitive rats. , 1997, American journal of hypertension.

[21]  S. Rajagopalan,et al.  Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. , 1997, Circulation.

[22]  S. Rajagopalan,et al.  p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. , 1997, Circulation research.

[23]  H. Gavras,et al.  Models of experimental hypertension in mice. , 1996, Hypertension.

[24]  M. Ushio-Fukai,et al.  p22phox Is a Critical Component of the Superoxide-generating NADH/NADPH Oxidase System and Regulates Angiotensin IIinduced Hypertrophy in Vascular Smooth Muscle Cells* , 1996, The Journal of Biological Chemistry.

[25]  A. Chobanian,et al.  Effects of angiotensin II infusion and inhibition of nitric oxide synthase on the rat aorta. , 1996, Hypertension.

[26]  E. Frohlich Intervention trials: concerns and publishing pitfalls. , 1996, Hypertension.

[27]  D. Harrison,et al.  Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. , 1996, The Journal of clinical investigation.

[28]  T. Lüscher,et al.  Direct in situ measurement of nitric oxide in mesenteric resistance arteries. Increased decomposition by superoxide in hypertension. , 1996, Hypertension.

[29]  J. Beckman,et al.  The importance of superoxide in nitric oxide-dependent toxicity: evidence for peroxynitrite-mediated injury. , 1996, Advances in experimental medicine and biology.

[30]  M. Moskowitz,et al.  Hypertension in mice lacking the gene for endothelial nitric oxide synthase , 1995, Nature.

[31]  J. Morrow,et al.  Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite. , 1995, Circulation research.

[32]  C. Epstein,et al.  Transgenic copper/zinc superoxide dismutase modulates susceptibility to type I diabetes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R W Alexander,et al.  Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. , 1994, Circulation research.

[34]  R. Tabach,et al.  Supersensitivity to morphine of the transmurally stimulated vas deferens isolated from ethanol-pretreated mice. , 1992, European journal of pharmacology.

[35]  S. Moncada,et al.  Nitric oxide synthase inhibitors cause sustained, but reversible, hypertension and hindquarters vasoconstriction in Brattleboro rats. , 1992, European journal of pharmacology.

[36]  C. Epstein,et al.  Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Sasaki,et al.  Does superoxide underlie the pathogenesis of hypertension? , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Mulvany,et al.  Angiotensin II Causes Vascular Hypertrophy in Part by a Non‐pressor Mechanism , 1991, Hypertension.

[39]  S. Moncada,et al.  Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo , 1990, British journal of pharmacology.

[40]  M. Lovett,et al.  Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[41]  D. Cox,et al.  Genes coding for sensitivity to interferon (IfRec) and soluble superoxide dismutase (SOD-1) are linked in mouse and man and map to mouse chromosome 16. , 1980, Proceedings of the National Academy of Sciences of the United States of America.